Objective To determine the eÂects of isoniazid (isonicot-Results Continuous incubation of proliferating T24, TCC-SUP and BT-B cells with isoniazid at concen-inic acid hydrazide), used to reduce the serious side-eÂects of immunotherapy of superficial bladder cancer trations of 0-100 mg/mL did not aÂect the rate of proliferation. Unlike TCC-SUP and BT-B cells, T24 cells with bacille Calmette-Guérin (BCG), on the proliferation and constitutive BCG-induced synthesis of released more IL6 and IL8 during incubation with BCG. At 6 h after the addition of BCG, the cumulative interleukins 6 (IL6) and 8 (IL8) in human bladder cancer cells cultured in vitro.
Objective To determine the eÂects of isoniazid (isonicot-Results Continuous incubation of proliferating T24, TCC-SUP and BT-B cells with isoniazid at concen-inic acid hydrazide), used to reduce the serious side-eÂects of immunotherapy of superficial bladder cancer trations of 0-100 mg/mL did not aÂect the rate of proliferation. Unlike TCC-SUP and BT-B cells, T24 cells with bacille Calmette-Guérin (BCG), on the proliferation and constitutive BCG-induced synthesis of released more IL6 and IL8 during incubation with BCG. At 6 h after the addition of BCG, the cumulative interleukins 6 (IL6) and 8 (IL8) in human bladder cancer cells cultured in vitro. mean (sd) IL6 and IL8 production of T24 cells was 2.6 (0.1) and 2.3 (0.4) ng per 3×105 cells, compared Materials and methods Three poorly diÂerentiated human cell lines, T24, TCC-SUP and BT-B, were used with a constitutive level of 0.1 (0.0) and 1.3 (0.2) ng, respectively. There was no significant eÂect of isoniazid to study the eÂect of isoniazid on cell proliferation. Cells were inoculated in tissue culture plates and (1-100 mg/mL) on either the constitutive or BCGinduced synthesis of IL6 and IL8 in T24 cells. various concentrations of isoniazid added to the medium. Cell density was then monitored for up to 6
Conclusion Assuming an essential role of (tumour) epithelial cells in the local immune response induced by days using a colorimetric assay. To determine the eÂects of isoniazid on constitutive and BCG-induced BCG, these in vitro results suggest that the administration of isoniazid does not interfere with this part of cytokine synthesis, cells were cultured in medium Introduction induced antitumour activity are scarce or lacking. Conflicting results about the eÂect of isoniazid on the Intravesical therapy with BCG against superficial bladder cancer recurrences and carcinoma in situ has been BCG-associated immune reaction have been reported; animal studies indicated either an impairment of BCG-shown to be highly eÂective in many clinical trials [1, 2] . Although being an attenuated strain of Mycobacterium induced reactions or absence of an isoniazid-associated eÂect [5] [6] [7] [8] . No impairment by isoniazid of the local bovis without virulence, about 5% of patients present with moderate to severe local or systemic adverse eÂects immunological stimulation after BCG instillation has been reported in man, suggesting that isoniazid does not after treatment with BCG, necessitating treatment with the tuberculostatic agent isoniazid [3] . The prophylactic aÂect the antitumour eÃcacy of BCG [9]. BCG-mediated antitumour activity is probably associated with local administration of isoniazid, initiated before BCG instillation, has been considered to diminish these side-eÂects immunological phenomena [10], but the detailed mode of action is not clearly understood [11] . When used and currently the prophylactic use of isoniazid is being investigated in a clinical trial [4] . However, the prophy-prophylactically, isoniazid may interfere at all levels within the complex host response to BCG, in addition to lactic application of isoniazid assumes that it does not adversely aÂect the BCG-induced activity against the its direct antitubercular properties on BCG viability [12] . The present study addresses the direct and indirect eÂects tumour. Data on potentially interfering eÂects of isoniazid of isoniazid associated with BCG on urothelial tumour cell lines, modelling the possible interference of isoniazid Accepted for publication 18 February 1997 with the initial interaction between BCG and urothelial on the first column of control wells containing medium (without cells) and XTT solution; isoniazid did not inter-cells. Presuming that urothelial cells contribute significantly as participants in the locally induced immune fere with the assay. In some experiments, data obtained with the XTT assay were verified by cell counting with response [11, 13] , the influence of isoniazid on cell proliferation and gene expression was determined in several a Coulter counter and/or a haemocytometer.
To determine the eÂects of isoniazid on constitutive human bladder tumour cell lines. and BCG-induced cytokine synthesis, cells (3×105) were cultured for 24 h in 24-well plates containing 1 mL
Materials and methods medium/well. Subsequently, the medium was replaced with medium containing (i) no additions, (ii) BCG (1 or Three poorly diÂerentiated human cell lines, T24, TCC-SUP and BT-B, were used; detailed information (e.g.
5×106 c.f.u.), (iii) isoniazid (100 mg/mL) or (iv) BCG and isoniazid at these concentrations. Medium was col-origin, stage and grade) about the T24 and TCC-SUP cell lines was reported previously [14, 15] 
Results
MA, USA). A vial-lyophilized BCG, strain Connaught (Connaught Laboratories, North York, Canada) contain-Addition of isoniazid at concentrations of 1-100 mg/mL at 24 h after inoculation appeared to have no eÂect on ing 1.9×108 c.f.u. of BCG per vial was reconstituted in prewarmed culture medium to the appropriate concen-the proliferation of T24, TCC-SUP and BT-A cells (Fig. 1) . Initially, the constitutive and BCG-induced upregulation tration for experiments.
To determine the eÂect of isoniazid on bladder tumour of IL6 and IL8 of the three bladder cancer cell lines was determined. BCG was applied as an inducer, as a BCG-cell proliferation, 2.5×103 cells were inoculated in 96-well flat-bottom tissue culture plates containing associated upregulation of the synthesis of various cytokines has been reported in the T24 bladder cancer cell 100 mL medium. After 24 h the cells were refreshed with RPMI-1640 (100 mL) without or with various concen-line in vitro [13] . The present results indicated that BCG upregulated the synthesis of both IL6 and IL8 in T24 trations (1-100 mg/mL) of isoniazid (Sigma, St Louis, MI, USA). Cell density was monitored for up to 6 days cells, but not in TCC-SUP and BT-A cells (Table 1) . Moreover, T24 cells showed a profound constitutive using a colorimetric assay measuring the formation of a formazan dye, soluble in aqueous solutions, from XTT synthesis of IL8 compared with BT-B and TCC-SUP cells. Because both IL6 and IL8 synthesis were upregulated (sodium 3∞-[1-(phenylaminocarbonyl)-3,4-tetrazolium]bis (4-methoxy-6-nitro) benzene sulphonic acid hydrate) by BCG in T24 cells, the eÂect of 1-100 mg/mL isoniazid on the constitutive and BCG-induced synthesis of IL6 [17] . Briefly, 50 mL XTT solution, containing 1 mg XTT per 1 mL RPMI-1640 and 0.383 mg N-methyl dibenzo-and IL8 was determined in this cell line. However, a control experiment was performed to determine whether pyrazine methyl sulphate (Sigma) per 1 mL PBS, was added to the cultures. After incubation for 3 h at 37°C, the penicillin and streptomycin in the culture medium interfered with the capacity of BCG to induce cytokine the optical density was read at 490 nm and 650 nm as a reference wavelength using a microplate reader synthesis in T24 cells. The BCG-associated upregulation of IL6 and IL8 in the presence and absence of penicillin (Thermomax, Molecular Devices, Sopachem, Lunteren, The Netherlands). The spectrophotometer was blanked and streptomycin was similar, suggesting that there was no interference with the BCG-induced upregulation of the cytokines within the duration of the experiments. The presence of isoniazid did not interfere with the observed continuous, linear increase of either constitutive or BCG-induced production of IL6 and IL8 ( Table 2 ). In addition, there was no eÂect of isoniazid on the relatively high constitutive synthesis of IL6 in TCC-SUP cells (results not shown).
Discussion
Several lines of evidence indicate that (specialized) epithelial cells, such as mature pulmonary epithelial cells, may contribute to the host defence system through interactions with inflammatory cells [21] . It has been suggested that uroepithelial cells are part of a mucosal cytokine network, depending on microbial stimulation Table 2 Cumulative production of constitutive and BCG-induced IL6 and IL8 in the medium of T24 cells during 6 h in the absence and presence of isoniazid intravesical therapy in superficial bladder cancer. J Urol of epithelial cells, as is the case in urinary tract infections 1992; 147: 596-600 [22] . During intravesical therapy of superficial bladder 4 Van der Meijden APM. Practical approaches to the cancer with BCG, urothelial (tumour) cells are exposed prevention and treatment of adverse reactions to BCG. Eur to BCG mycobacteria. In vitro, this situation has been Urol 1995; 27 (suppl 1): shown to upregulate cytokine synthesis by human blad- (EORTC protocol 30911) [4] . In conclusion, the present results suggest that the 
